Global Gene Sequencing Service Market Research Report 2022
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Sequencing Service Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
- 1.2.2 Second-generation Sequencing
- 1.2.3 Third and Fourth Generation Sequencing
- 1.2.4 First-generation Sequencing
- 1.3 Market by Application
- 1.3.1 Global Gene Sequencing Service Market Share by Application: 2017 VS 2021 VS 2028
- 1.3.2 Academic Research
- 1.3.3 Clinical Research
- 1.3.4 Hospital Clinic
- 1.3.5 Pharmaceutical and Biotechnology
- 1.3.6 Other
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Gene Sequencing Service Market Perspective (2017-2028)
- 2.2 Gene Sequencing Service Growth Trends by Region
- 2.2.1 Gene Sequencing Service Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Gene Sequencing Service Historic Market Size by Region (2017-2022)
- 2.2.3 Gene Sequencing Service Forecasted Market Size by Region (2023-2028)
- 2.3 Gene Sequencing Service Market Dynamics
- 2.3.1 Gene Sequencing Service Industry Trends
- 2.3.2 Gene Sequencing Service Market Drivers
- 2.3.3 Gene Sequencing Service Market Challenges
- 2.3.4 Gene Sequencing Service Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Gene Sequencing Service Players by Revenue
- 3.1.1 Global Top Gene Sequencing Service Players by Revenue (2017-2022)
- 3.1.2 Global Gene Sequencing Service Revenue Market Share by Players (2017-2022)
- 3.2 Global Gene Sequencing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Gene Sequencing Service Revenue
- 3.4 Global Gene Sequencing Service Market Concentration Ratio
- 3.4.1 Global Gene Sequencing Service Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Gene Sequencing Service Revenue in 2021
- 3.5 Gene Sequencing Service Key Players Head office and Area Served
- 3.6 Key Players Gene Sequencing Service Product Solution and Service
- 3.7 Date of Enter into Gene Sequencing Service Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Sequencing Service Breakdown Data by Type
- 4.1 Global Gene Sequencing Service Historic Market Size by Type (2017-2022)
- 4.2 Global Gene Sequencing Service Forecasted Market Size by Type (2023-2028)
5 Gene Sequencing Service Breakdown Data by Application
- 5.1 Global Gene Sequencing Service Historic Market Size by Application (2017-2022)
- 5.2 Global Gene Sequencing Service Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Gene Sequencing Service Market Size (2017-2028)
- 6.2 North America Gene Sequencing Service Market Size by Country (2017-2022)
- 6.3 North America Gene Sequencing Service Market Size by Country (2023-2028)
- 6.4 United States
- 6.5 Canada
7 Europe
- 7.1 Europe Gene Sequencing Service Market Size (2017-2028)
- 7.2 Europe Gene Sequencing Service Market Size by Country (2017-2022)
- 7.3 Europe Gene Sequencing Service Market Size by Country (2023-2028)
- 7.4 Germany
- 7.5 France
- 7.6 U.K.
- 7.7 Italy
- 7.8 Russia
- 7.9 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Gene Sequencing Service Market Size (2017-2028)
- 8.2 Asia-Pacific Gene Sequencing Service Market Size by Country (2017-2022)
- 8.3 Asia-Pacific Gene Sequencing Service Market Size by Country (2023-2028)
- 8.4 China
- 8.5 Japan
- 8.6 South Korea
- 8.7 Southeast Asia
- 8.8 India
- 8.9 Australia
9 Latin America
- 9.1 Latin America Gene Sequencing Service Market Size (2017-2028)
- 9.2 Latin America Gene Sequencing Service Market Size by Country (2017-2022)
- 9.3 Latin America Gene Sequencing Service Market Size by Country (2023-2028)
- 9.4 Mexico
- 9.5 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Gene Sequencing Service Market Size (2017-2028)
- 10.2 Middle East & Africa Gene Sequencing Service Market Size by Country (2017-2022)
- 10.3 Middle East & Africa Gene Sequencing Service Market Size by Country (2023-2028)
- 10.4 Turkey
- 10.5 Saudi Arabia
- 10.6 UAE
11 Key Players Profiles
- 11.1 Illumina
- 11.1.1 Illumina Company Detail
- 11.1.2 Illumina Business Overview
- 11.1.3 Illumina Gene Sequencing Service Introduction
- 11.1.4 Illumina Revenue in Gene Sequencing Service Business (2017-2022)
- 11.1.5 Illumina Recent Development
- 11.2 Eurofins Scientific
- 11.2.1 Eurofins Scientific Company Detail
- 11.2.2 Eurofins Scientific Business Overview
- 11.2.3 Eurofins Scientific Gene Sequencing Service Introduction
- 11.2.4 Eurofins Scientific Revenue in Gene Sequencing Service Business (2017-2022)
- 11.2.5 Eurofins Scientific Recent Development
- 11.3 BGI
- 11.3.1 BGI Company Detail
- 11.3.2 BGI Business Overview
- 11.3.3 BGI Gene Sequencing Service Introduction
- 11.3.4 BGI Revenue in Gene Sequencing Service Business (2017-2022)
- 11.3.5 BGI Recent Development
- 11.4 Natera
- 11.4.1 Natera Company Detail
- 11.4.2 Natera Business Overview
- 11.4.3 Natera Gene Sequencing Service Introduction
- 11.4.4 Natera Revenue in Gene Sequencing Service Business (2017-2022)
- 11.4.5 Natera Recent Development
- 11.5 Berry Genomics
- 11.5.1 Berry Genomics Company Detail
- 11.5.2 Berry Genomics Business Overview
- 11.5.3 Berry Genomics Gene Sequencing Service Introduction
- 11.5.4 Berry Genomics Revenue in Gene Sequencing Service Business (2017-2022)
- 11.5.5 Berry Genomics Recent Development
- 11.6 Roche
- 11.6.1 Roche Company Detail
- 11.6.2 Roche Business Overview
- 11.6.3 Roche Gene Sequencing Service Introduction
- 11.6.4 Roche Revenue in Gene Sequencing Service Business (2017-2022)
- 11.6.5 Roche Recent Development
- 11.7 Novogene
- 11.7.1 Novogene Company Detail
- 11.7.2 Novogene Business Overview
- 11.7.3 Novogene Gene Sequencing Service Introduction
- 11.7.4 Novogene Revenue in Gene Sequencing Service Business (2017-2022)
- 11.7.5 Novogene Recent Development
- 11.8 LabCorp
- 11.8.1 LabCorp Company Detail
- 11.8.2 LabCorp Business Overview
- 11.8.3 LabCorp Gene Sequencing Service Introduction
- 11.8.4 LabCorp Revenue in Gene Sequencing Service Business (2017-2022)
- 11.8.5 LabCorp Recent Development
- 11.9 Pacific Biosciences
- 11.9.1 Pacific Biosciences Company Detail
- 11.9.2 Pacific Biosciences Business Overview
- 11.9.3 Pacific Biosciences Gene Sequencing Service Introduction
- 11.9.4 Pacific Biosciences Revenue in Gene Sequencing Service Business (2017-2022)
- 11.9.5 Pacific Biosciences Recent Development
- 11.10 Azenta Life Sciences
- 11.10.1 Azenta Life Sciences Company Detail
- 11.10.2 Azenta Life Sciences Business Overview
- 11.10.3 Azenta Life Sciences Gene Sequencing Service Introduction
- 11.10.4 Azenta Life Sciences Revenue in Gene Sequencing Service Business (2017-2022)
- 11.10.5 Azenta Life Sciences Recent Development
- 11.11 Oxford Nanopore
- 11.11.1 Oxford Nanopore Company Detail
- 11.11.2 Oxford Nanopore Business Overview
- 11.11.3 Oxford Nanopore Gene Sequencing Service Introduction
- 11.11.4 Oxford Nanopore Revenue in Gene Sequencing Service Business (2017-2022)
- 11.11.5 Oxford Nanopore Recent Development
- 11.12 Macrogen
- 11.12.1 Macrogen Company Detail
- 11.12.2 Macrogen Business Overview
- 11.12.3 Macrogen Gene Sequencing Service Introduction
- 11.12.4 Macrogen Revenue in Gene Sequencing Service Business (2017-2022)
- 11.12.5 Macrogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
Summary:
Gene sequencing is a new type of gene detection technology that can analyze and determine the complete sequence of genes from blood or saliva, predict the possibility of suffering from a variety of diseases, and individual behavior characteristics and behaviors are reasonable. Gene sequencing technology can lock individual disease genes, prevent and treat them in advance. Gene sequencing-related products and technologies have evolved from laboratory research to clinical use. It can be said that gene sequencing technology is the next technology that will change the world.
Industry Insights
The global Gene Sequencing Service market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Second-generation Sequencing accounting for % of the Gene Sequencing Service global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Academic Research segment is altered to an % CAGR throughout this forecast period.
China Gene Sequencing Service market size is valued at US$ million in 2021, while the North America and Europe Gene Sequencing Service are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Gene Sequencing Service landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Sequencing Service market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Sequencing Service market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Sequencing Service market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Sequencing Service market.
Impact of Covid-19 Outbreak
This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.
Segmental Analysis
The report has been segmented into product and application segments. The researchers have documented all the products present today in the Gene Sequencing Service market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.
Gene Sequencing Service Breakdown Data by Type
Second-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing
Gene Sequencing Service Breakdown Data by Application
Academic Research
Clinical Research
Hospital Clinic
Pharmaceutical and Biotechnology
Other
Regional Analysis
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:
Illumina
Eurofins Scientific
BGI
Natera
Berry Genomics
Roche
Novogene
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen
Frequently Asked Questions
What factors will challenge the Gene Sequencing Service market growth?
Which end-use segment will expand at the fastest CAGR in the Gene Sequencing Service market?
Which are the emerging players in the Gene Sequencing Service market?
How concentrated is the Gene Sequencing Service market?
Which factors are positively contributing to the Gene Sequencing Service market growth?
Which are the novel product innovations in the Gene Sequencing Service market?
Which product segment will emerge as the most lucrative in the Gene Sequencing Service market?
Which factors are increasing the competition in the Gene Sequencing Service market?
Which are the strategic measures taken by the Gene Sequencing Service industry players?
Which region will witness inactive growth during the forecast period?
What key trends are likely to emerge in the Gene Sequencing Service market in the coming years?